Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
52.72
-2.08 (-3.80%)
Mar 31, 2025, 1:27 PM EDT - Market open
Rhythm Pharmaceuticals Employees
Rhythm Pharmaceuticals had 283 employees as of December 31, 2024. The number of employees increased by 57 or 25.22% compared to the previous year.
Employees
283
Change (1Y)
57
Growth (1Y)
25.22%
Revenue / Employee
$459,809
Profits / Employee
-$934,883
Market Cap
3.33B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
RYTM News
- 10 days ago - Rhythm Pharmaceuticals Reacquires Licensing Rights to IMCIVREE® (setmelanotide) in China with Termination of Agreement with RareStone Ltd. - GlobeNewsWire
- 11 days ago - Rhythm Pharmaceuticals Announces Orphan Drug Designation Granted to Setmelanotide for Treatment of Hypothalamic Obesity in Japan - GlobeNewsWire
- 13 days ago - Rhythm Pharmaceuticals and Raymond A. Wood Foundation Announce Research Collaboration - GlobeNewsWire
- 4 weeks ago - Rhythm Pharmaceuticals, Inc. (RYTM) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Business Update - GlobeNewsWire
- 4 weeks ago - Rhythm Pharmaceuticals: Buying This Rare Genetic Obesity Maven - Seeking Alpha
- 6 weeks ago - Rhythm Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on Wednesday, February 26, 2025 - GlobeNewsWire
- 2 months ago - Rhythm Pharmaceuticals Announces Preliminary Fourth Quarter and Full Year 2024 Net Product Revenues, Pipeline Advancements and Upcoming Milestones - GlobeNewsWire